β blockers for the treatment of primary hypertension
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference5 articles.
1. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis;Lindholm;Lancet,2005
2. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study;Franklin;Circulation,2005
3. MRC trial of treatment of mild hypertension: principal results;BMJ,1985
4. Medical Research Council Trial of treatment of hypertension in older adults: principal results;BMJ,1992
5. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39;BMJ,1998
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hypertension Controversies;Contemporary Cardiology;2014-10-04
2. EFFECT OF 35 YEARS BETA-ADRENERGIC BLOCKADE THERAPY ON AUTONOMIC CARDIOVASCULAR MODULATION. A CASE STUDY;Acta Clinica Belgica;2009-12
3. Role of beta-adrenergic receptor blocking agents in hypertensive diseases: personal thoughts as the controversy persists;Therapeutic Advances in Cardiovascular Disease;2009-11-06
4. Are we misunderstanding beta-blockers;International Journal of Cardiology;2007-08
5. Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?;Current Hypertension Reviews;2007-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3